Valentin Fuster Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

10/2014	Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling.
8/2013	Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis.
10/2011	Increased macrophage infiltration and neovascularization in congenital bicuspid aortic valve stenosis.
10/2004	Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Valentin Fuster Research Topics

Disease

56	Atherosclerosis 01/2022 - 06/2002
39	Atherosclerotic Plaque (Atheroma) 01/2021 - 02/2002
37	Inflammation (Inflammations) 01/2022 - 04/2004
37	Myocardial Infarction 01/2022 - 11/2002
36	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 05/2003
29	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2003
22	Thrombosis (Thrombus) 10/2022 - 11/2002
20	Heart Failure 01/2022 - 09/2005
20	Hypertension (High Blood Pressure) 01/2022 - 09/2007
19	Diabetes Mellitus 01/2022 - 07/2007
18	ST Elevation Myocardial Infarction 01/2021 - 05/2003
17	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2004
17	Infarction (Infarctions) 11/2020 - 03/2011
16	Hemorrhage 01/2021 - 01/2004
16	Acute Coronary Syndrome 05/2017 - 02/2002
15	Atrial Fibrillation 04/2020 - 12/2007
11	Stroke (Strokes) 01/2022 - 08/2011
11	Heart Valve Diseases (Valvular Heart Disease) 01/2021 - 03/2010
9	Fibrosis (Cirrhosis) 01/2021 - 07/2011
8	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2014
8	COVID-19 01/2022 - 01/2020
8	Ischemia 01/2021 - 08/2013
8	Pathologic Constriction (Stenosis) 01/2020 - 05/2004
7	Rupture 01/2021 - 05/2002
7	Type 2 Diabetes Mellitus (MODY) 11/2020 - 02/2003
6	Left Ventricular Dysfunction 11/2020 - 04/2007
6	Neointima 10/2014 - 04/2003
5	Aneurysm (Aneurysms) 10/2014 - 02/2005
5	Vascular Diseases (Vascular Disease) 06/2010 - 03/2006
4	Congenital Heart Defects (Congenital Heart Defect) 01/2022 - 01/2018
4	Myocarditis (Carditis) 01/2022 - 11/2015
4	Cardiotoxicity 01/2022 - 11/2014
4	Thromboembolism 01/2022 - 05/2012
4	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020 - 02/2015
4	Chronic Renal Insufficiency 05/2020 - 09/2013
4	Reperfusion Injury 01/2020 - 03/2011
4	Hypoxia (Hypoxemia) 01/2015 - 08/2013
4	Peripheral Arterial Disease 06/2008 - 03/2006
4	Hypercholesterolemia 05/2008 - 12/2002
3	Ventricular Tachycardia 05/2022 - 08/2020
3	Dementia (Dementias) 01/2022 - 01/2020
3	Neoplasms (Cancer) 01/2021 - 11/2013
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 12/2017
3	Insulin Resistance 12/2020 - 12/2004
3	Stable Angina 11/2020 - 10/2004

Drug/Important Bio-Agent (IBA)

40	LipidsIBA 01/2022 - 02/2002
18	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2007
15	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021 - 06/2007
14	CholesterolIBA 01/2021 - 07/2003
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 12/2002
10	LDL CholesterolIBA 01/2021 - 07/2003
10	CalciumIBA 07/2017 - 03/2009
9	omega-Chloroacetophenone (Mace)IBA 01/2022 - 04/2009
9	oxidized low density lipoproteinIBA 01/2021 - 06/2008
9	CollagenIBA 01/2020 - 09/2003
9	Pharmaceutical PreparationsIBA 10/2018 - 03/2007
9	Thromboplastin (Tissue Factor)IBA 10/2014 - 02/2003
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 05/2003
8	Proteins (Proteins, Gene)FDA Link 10/2018 - 09/2003
8	Apolipoproteins E (ApoE)IBA 12/2016 - 06/2002
7	Hemoglobins (Hemoglobin)IBA 11/2019 - 01/2007
7	Contrast MediaIBA 09/2010 - 11/2004
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 06/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2012
6	GadoliniumIBA 10/2017 - 09/2005
6	Phenobarbital (Luminal)FDA Link 03/2013 - 09/2003
5	C-Reactive ProteinIBA 01/2022 - 07/2004
5	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2004
5	empagliflozinIBA 01/2021 - 01/2019
5	Thrombin FDA Link 01/2020 - 07/2004
5	Clopidogrel (Plavix)FDA Link 10/2017 - 05/2003
5	Warfarin (Coumadin)FDA LinkGeneric 05/2015 - 01/2004
5	HaptoglobinsIBA 11/2012 - 01/2007
4	Anti-Arrhythmia AgentsIBA 05/2022 - 01/2011
4	TroponinIBA 01/2021 - 01/2015
4	HDL CholesterolIBA 12/2020 - 07/2003
4	Troponin IIBA 11/2020 - 01/2015
4	Biological ProductsIBA 05/2017 - 11/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 10/2004
4	AnticoagulantsIBA 06/2014 - 08/2011
4	ApolipoproteinsIBA 01/2014 - 06/2002
4	HDL LipoproteinsIBA 01/2014 - 12/2004
4	Simvastatin (Zocor)FDA LinkGeneric 01/2012 - 02/2004
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2011 - 03/2008
4	Scavenger Receptors (Scavenger Receptor)IBA 09/2009 - 09/2006
3	AnthracyclinesIBA 01/2022 - 01/2019
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2003
3	Insulin (Novolin)FDA Link 10/2020 - 02/2007
3	Amyloid (Amyloid Fibrils)IBA 07/2020 - 01/2018
3	Dabigatran FDA Link 10/2019 - 03/2011
3	Angiotensin IIIBA 10/2018 - 12/2011

Therapy/Procedure

58	Therapeutics 05/2022 - 02/2002
27	Percutaneous Coronary Intervention 10/2022 - 10/2004
14	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2020 - 02/2013
9	Stents 10/2022 - 02/2005
6	Secondary Prevention 12/2017 - 05/2003
5	Drug Therapy (Chemotherapy) 01/2022 - 06/2008
5	Drug-Eluting Stents 01/2019 - 12/2012
5	Catheter Ablation 11/2012 - 04/2008
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 05/2022 - 02/2006